• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Retinopathy of prematurity: Past, present and future.早产儿视网膜病变:过去、现在与未来。
World J Clin Pediatr. 2016 Feb 8;5(1):35-46. doi: 10.5409/wjcp.v5.i1.35.
2
A Narrative Review on Managing Retinopathy of Prematurity: Insights Into Pathogenesis, Screening, and Treatment Strategies.关于早产儿视网膜病变管理的叙述性综述:对发病机制、筛查及治疗策略的见解
Cureus. 2024 Mar 14;16(3):e56168. doi: 10.7759/cureus.56168. eCollection 2024 Mar.
3
Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.早产儿视网膜病变:基于病理生理学的治疗策略
Neonatology. 2016;109(4):369-76. doi: 10.1159/000444901. Epub 2016 Jun 3.
4
Retinopathy of Prematurity: Clinical Features, Classification, Natural History, Management and Outcome.早产儿视网膜病变:临床特征、分类、自然病程、管理及预后
Indian Pediatr. 2016 Nov 7;53 Suppl 2:S118-S122.
5
Retinopathy of Prematurity: How to Prevent the Third Epidemics in Developing Countries.早产儿视网膜病变:如何预防发展中国家的第三次流行。
Asia Pac J Ophthalmol (Phila). 2020 Sep-Oct;9(5):440-448. doi: 10.1097/APO.0000000000000313.
6
An Update on Retinopathy of Prematurity (ROP).早产儿视网膜病变(ROP)的最新进展。
Indian J Pediatr. 2017 Dec;84(12):930-936. doi: 10.1007/s12098-017-2404-3. Epub 2017 Jul 4.
7
Lack of Screening Underlies Most Stage-5 Retinopathy of Prematurity among Cases Presenting to a Tertiary Eye Center in India.在印度一家三级眼科中心就诊的病例中,筛查不足是大多数5期早产儿视网膜病变的根本原因。
Indian Pediatr. 2016 Nov 7;53 Suppl 2:S103-S106.
8
Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries.抗血管内皮生长因子(Anti-VEGF)在早产儿视网膜病变治疗中的作用:基于中等收入国家背景的叙述性综述
Pediatric Health Med Ther. 2023 Feb 15;14:59-69. doi: 10.2147/PHMT.S391591. eCollection 2023.
9
[Emphasizing the prevention and treatment for retinopathy of prematurity].强调早产儿视网膜病变的防治
Zhonghua Yan Ke Za Zhi. 2005 Apr;41(4):289-91.
10
Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen.21世纪的早产儿视网膜病变及补充氧气的复杂影响。
J Clin Med. 2023 Feb 3;12(3):1228. doi: 10.3390/jcm12031228.

引用本文的文献

1
Polystyrene microplastics impair the function of human retinal microvascular endothelial cells and pericytes and increase vascular permeability .聚苯乙烯微塑料会损害人视网膜微血管内皮细胞和周细胞的功能,并增加血管通透性。
Front Med (Lausanne). 2025 Jun 24;12:1587759. doi: 10.3389/fmed.2025.1587759. eCollection 2025.
2
Incidence and risk factors of retinopathy of prematurity in Palestine: a retrospective cohort study, 2024.巴勒斯坦早产儿视网膜病变的发病率及危险因素:一项2024年的回顾性队列研究
BMC Ophthalmol. 2025 May 30;25(1):324. doi: 10.1186/s12886-025-04152-2.
3
AI-Enabled Screening for Retinopathy of Prematurity in Low-Resource Settings.在资源匮乏地区利用人工智能进行早产儿视网膜病变筛查。
JAMA Netw Open. 2025 Apr 1;8(4):e257831. doi: 10.1001/jamanetworkopen.2025.7831.
4
The use of neural networks to determine factors affecting the severity and extent of retinopathy in preterm infants.利用神经网络确定影响早产儿视网膜病变严重程度和范围的因素。
Int J Retina Vitreous. 2025 Mar 14;11(1):30. doi: 10.1186/s40942-025-00650-z.
5
The Role of Acute Phase Reactants, Including α1-Acid Glycoprotein, in Predicting Onset and Severity of Retinopathy of Prematurity.急性期反应物,包括α1-酸性糖蛋白,在预测早产儿视网膜病变的发病和严重程度中的作用。
Diagnostics (Basel). 2025 Feb 27;15(5):571. doi: 10.3390/diagnostics15050571.
6
Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity.补充叶酸可抑制早产儿增殖性视网膜病变。
Biomolecules. 2025 Feb 19;15(2):309. doi: 10.3390/biom15020309.
7
Prevalence and associated factors for retinopathy of prematurity at a tertiary hospital in Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆一家三级医院早产儿视网膜病变的患病率及相关因素
Eye (Lond). 2025 Jun;39(8):1476-1480. doi: 10.1038/s41433-025-03651-2. Epub 2025 Feb 13.
8
Clinicoepidemiological Profile of Retinopathy of Prematurity.早产儿视网膜病变的临床流行病学概况
Cureus. 2024 Sep 21;16(9):e69831. doi: 10.7759/cureus.69831. eCollection 2024 Sep.
9
Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters.利用血浆胰岛素样生长因子1(IGF1)、肿瘤坏死因子-α(TNF-α)水平及新生儿参数预测早产儿视网膜病变风险
Clin Pract. 2024 Aug 1;14(4):1515-1528. doi: 10.3390/clinpract14040122.
10
Assessing spectral effectiveness in color fundus photography for deep learning classification of retinopathy of prematurity.评估眼底彩色摄影的光谱有效性,用于早产儿视网膜病变的深度学习分类。
J Biomed Opt. 2024 Jul;29(7):076001. doi: 10.1117/1.JBO.29.7.076001. Epub 2024 Jun 18.

本文引用的文献

1
Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment.需要治疗的早产儿视网膜病变检测中范式转变的可能性。
Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F6-9. doi: 10.1136/archdischild-2015-308704. Epub 2015 Jul 24.
2
Genetic and Environmental Influences on Retinopathy of Prematurity.遗传和环境因素对早产儿视网膜病变的影响
Mediators Inflamm. 2015;2015:764159. doi: 10.1155/2015/764159. Epub 2015 May 21.
3
Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.早产儿视网膜病变集中分级验证系统:评估早产儿急性期视网膜病变(e-ROP)的远程医疗方法研究。
JAMA Ophthalmol. 2015 Jun;133(6):675-82. doi: 10.1001/jamaophthalmol.2015.0460.
4
Reactivation of retinopathy of prematurity after ranibizumab treatment.雷珠单抗治疗后早产儿视网膜病变复发。
Retina. 2015 Apr;35(4):675-80. doi: 10.1097/IAE.0000000000000578.
5
Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.早产儿视网膜病变玻璃体内注射贝伐单抗后血清血管内皮生长因子及相关因子水平。
JAMA Ophthalmol. 2015 Apr;133(4):391-7. doi: 10.1001/jamaophthalmol.2014.5373.
6
Telemedicine for evaluation of retinopathy of prematurity.早产儿视网膜病变的远程医疗评估。
Pediatrics. 2015 Jan;135(1):e238-54. doi: 10.1542/peds.2014-0978.
7
Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review.新西兰早产儿视网膜病变(ROP)所致视力损害:一项为期22年的回顾。
Br J Ophthalmol. 2015 Jun;99(6):801-6. doi: 10.1136/bjophthalmol-2014-305913. Epub 2014 Dec 19.
8
Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study.在评估早产儿急性期视网膜病变(电子视网膜病变)的远程医疗方法中,转诊指征性早产儿视网膜病变发生的预测因素研究。
JAMA Ophthalmol. 2015 Mar;133(3):304-11. doi: 10.1001/jamaophthalmol.2014.5185.
9
Structural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retinopathy of prematurity.玻璃体内注射阿柏西普治疗高危阈值前1型早产儿视网膜病变的结构、视觉和屈光结果
Ophthalmic Res. 2015;53(1):15-20. doi: 10.1159/000364809. Epub 2014 Nov 29.
10
Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab.玻璃体内注射抗血管内皮生长因子治疗早产儿视网膜病变:雷珠单抗与贝伐单抗的比较。
Retina. 2015 Apr;35(4):667-74. doi: 10.1097/IAE.0000000000000380.

早产儿视网膜病变:过去、现在与未来。

Retinopathy of prematurity: Past, present and future.

作者信息

Shah Parag K, Prabhu Vishma, Karandikar Smita S, Ranjan Ratnesh, Narendran Venkatapathy, Kalpana Narendran

机构信息

Parag K Shah, Vishma Prabhu, Smita S Karandikar, Ratnesh Ranjan, Venkatapathy Narendran, Narendran Kalpana, Pediatric Retina and Ocular Oncology Department, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore 641014, Tamilnadu, India.

出版信息

World J Clin Pediatr. 2016 Feb 8;5(1):35-46. doi: 10.5409/wjcp.v5.i1.35.

DOI:10.5409/wjcp.v5.i1.35
PMID:26862500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4737691/
Abstract

Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina occurring principally in new born preterm infants. It is an avoidable cause of childhood blindness. With the increase in the survival of preterm babies, ROP has become the leading cause of preventable childhood blindness throughout the world. A simple screening test done within a few weeks after birth by an ophthalmologist can avoid this preventable blindness. Although screening guidelines and protocols are strictly followed in the developed nations, it lacks in developing economies like India and China, which have the highest number of preterm deliveries in the world. The burden of this blindness in these countries is set to increase tremendously in the future, if corrective steps are not taken immediately. ROP first emerged in 1940s and 1950s, when it was called retrolental fibroplasia. Several epidemics of this disease were and are still occurring in different regions of the world and since then a lot of research has been done on this disease. However, till date very few comprehensive review articles covering all the aspects of ROP are published. This review highlights the past, present and future strategies in managing this disease. It would help the pediatricians to update their current knowledge on ROP.

摘要

早产儿视网膜病变(ROP)是一种主要发生于早产新生儿的视网膜血管增生性疾病。它是儿童失明的一个可避免病因。随着早产婴儿存活率的提高,ROP已成为全球可预防儿童失明的首要原因。出生后几周内由眼科医生进行的一项简单筛查测试可避免这种可预防的失明。尽管发达国家严格遵循筛查指南和方案,但在印度和中国等发展中经济体却缺乏相关措施,而这两个国家的早产分娩数量位居世界之首。如果不立即采取纠正措施,未来这些国家这种失明的负担将大幅增加。ROP最早出现在20世纪40年代和50年代,当时被称为晶状体后纤维增生症。这种疾病的几次流行过去和现在都在世界不同地区发生,从那时起针对这种疾病已经开展了大量研究。然而,迄今为止,很少有涵盖ROP所有方面的全面综述文章发表。本综述重点介绍了管理这种疾病的过去、现在和未来策略。它将有助于儿科医生更新他们目前关于ROP的知识。